Spanish Red Biotech Pipeline

Gilead Sciences

Etrumadenant + zimberelimab combinations

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Metastatic colorectal cancer
Phase: 2Phase II in Spain, 1Phase I in Spain